Quantcast

Myriad Genetics Inc. (MYGN) Is Climbing On Pfizer Deal


Shutterstock photo


(RTTNews.com) - Myriad Genetics Inc. ( MYGN ) announced Wednesday morning that it has signed a new laboratory services agreement with Pfizer Inc. (PFE).

Myriad Genetics gapped open higher Wednesday and has continued to rise in early trade. Shares are now up 4.16 at $47.35 on above average volume. The stock has climbed to a 2-week high.


Read the original article on RTTNews (http://www.rttnews.com/2942499/myriad-genetics-inc-mygn-is-climbing-on-pfizer-deal.aspx)


For comments and feedback: contact editorial@rttnews.com




This article appears in: US Markets , Stocks
Referenced Symbols: MYGN ,



More from RTT News

Subscribe






See All RTT news











Research Brokers before you trade

Want to trade FX?